Scarica l'app Stockscreener
0.5206
2.08%
0.0106
Dopo l'orario di chiusura:
.52
-0.0006
-0.12%
Precedente Chiudi:
$0.51
Aprire:
$0.505
Volume 24 ore:
549.80K
Relative Volume:
0.03
Capitalizzazione di mercato:
$21.15M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+3.48%
1M Prestazione:
-5.89%
6M Prestazione:
-64.34%
1 anno Prestazione:
-91.33%
Intervallo 1D:
$0.501
$0.536
Intervallo di 1 settimana:
$0.49
$0.536
Portata 52W:
$0.461
$6.4072
Scienture Holdings Inc Stock (SCNX) Company Profile
Nome
Scienture Holdings Inc
Settore
Industria
Telefono
(800) 261 0281
Indirizzo
20 AUSTIN BLVD., COMMACK
Confronta SCNX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SCNX
Scienture Holdings Inc
|
0.5206 | 20.72M | 0 | 0 | 0 | 0.00 |
|
HITI
High Tide Inc
|
2.80 | 230.84M | 376.07M | -22.41M | 18.73M | -0.298 |
|
PETS
Petmed Express Inc
|
3.30 | 68.38M | 270.52M | -6.08M | 17.42M | -0.2944 |
|
RDGT
Ridgetech Inc
|
2.66 | 52.11M | 119.97M | -1.45M | 632.50K | -0.9847 |
|
WGRX
Wellgistics Health Inc
|
0.4335 | 40.86M | 28.99M | -39.20M | -3.34M | 0.00 |
|
POM
Pomdoctor Ltd Adr
|
0.3259 | 35.15M | 0 | 0 | 0 | 0.00 |
Scienture Holdings Inc Borsa (SCNX) Ultime notizie
Scienture Holdings Inc. (SCNX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
MSN Money - MSN
Will Scienture Holdings Inc stock beat EPS estimates2025 Pullback Review & Weekly Return Optimization Alerts - moha.gov.vn
Scienture Holdings, Inc.Common Stock (Nasdaq:SCNX) Stock Quote - FinancialContent
Scienture Holdings, Inc. (SCNX) - Zacks Investment Research
Scienture Prepares Launch Of REZENOPY, Its Highest-Strength Naloxone Nasal Spray - Nasdaq
SCIENTURE Provides Update on the Commercial Launch of REZENOPY®, the Highest Strength Naloxone HCl Life-Saving Opioid Overdose Emergency Treatment Approved by the FDA - The Globe and Mail
Scienture to launch high-strength naloxone nasal spray in Q2 2026 - Investing.com Nigeria
Is Scienture Holdings Inc stock near bottom after declineJuly 2025 Analyst Calls & Safe Capital Growth Stock Tips - moha.gov.vn
Scienture (SCNX) Advances with REZENOPY Nasal Spray Launch - GuruFocus
Scienture to launch high-strength naloxone nasal spray in Q2 2026 By Investing.com - Investing.com South Africa
Scienture provides update on the commercial launch of Rezenopy - marketscreener.com
Scienture Provides Update On The Commercial Launch Of Rezenopy - TradingView — Track All Markets
New 10 mg overdose nasal spray set to reach U.S. market in 2026 - Stock Titan
Why Scienture Holdings Inc. stock is trending among retail tradersPrice Volatility Patterns & Master Technical Analysis With Free Tools - bollywoodhelpline.com
Is Scienture Holdings Inc. stock a top momentum playPortfolio Performance Summary & Low Drawdown Investment Strategies - Улправда
Will Scienture Holdings Inc. (4E4) stock announce a stock split2025 Retail Activity & Precise Swing Trade Alerts - Улправда
How Scienture Holdings Inc. stock trades during market volatility2025 Technical Overview & Precise Swing Trade Alerts - Улправда
Is Scienture Holdings Inc. (4E4) stock included in top ETFs2025 Winners & Losers & Free High Return Stock Watch Alerts - DonanımHaber
How Scienture Holdings Inc. stock reacts to inflationary pressuresWeekly Trade Review & Risk Controlled Swing Alerts - DonanımHaber
Is Scienture Holdings Inc. stock a good choice for value investorsWeekly Trade Report & Free Weekly Watchlist of Top Performers - DonanımHaber
Is Scienture Holdings Inc. stock positioned for digital transformationTrade Exit Report & Weekly Top Performers Watchlists - DonanımHaber
What analyst consensus implies for Scienture Holdings Inc. (4E4) stockShort Setup & Reliable Breakout Stock Forecasts - DonanımHaber
Movement Recap: Is Scienture Holdings Inc 4E4 stock included in top ETFsJuly 2025 PostEarnings & Low Risk High Reward Ideas - moha.gov.vn
Is Scienture Holdings Inc 4E4 stock included in top ETFsJuly 2025 PostEarnings & Low Risk High Reward Ideas - moha.gov.vn
Scienture, BlinkRx announce strategic collaboration to expand access to Arbli - Yahoo Finance
Why Is Scienture Stock Gaining Today? - Benzinga
Scienture and BlinkRx partner to expand access to liquid losartan By Investing.com - Investing.com Australia
SCNX FinancialsIncome Statement - Quiver Quantitative
SCIENTURE and BlinkRx Announce Strategic Collaboration to Expand Patient Access to Arbli™, the First FDA-Approved Ready-to-Use Oral Suspension of Losartan Potassium - The Manila Times
Scienture and BlinkRx partner to expand access to liquid losartan - Investing.com India
Scienture (NASDAQ: SCNX) taps BlinkRx to launch Arbli, first ready-to-use losartan oral suspension in Q1 2026 - Stock Titan
A significant driver of top-line growth: Scienture Holdings Inc (SCNX) - Setenews
Scienture Holdings, Inc. Cash Flow – HAM:4E4 - TradingView
Can Scienture Holdings Inc. (4E4) stock beat analyst consensusTrade Signal Summary & Consistent Return Strategy Ideas - Newser
Head to Head Analysis: Summit Therapeutics (NASDAQ:SMMT) and Scienture (NASDAQ:SCNX) - Defense World
Scienture Holdings Inc Azioni (SCNX) Dati Finanziari
Non sono disponibili dati finanziari per Scienture Holdings Inc (SCNX). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
2.13%
10.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):